The House Energy and Commerce Subcommittee on Energy and Power voted July 19 in favor of legislation that would increase the use of methyl bromide, a fumigant found to deplete the stratospheric ozone layer, and that would allow the sale of existing inventories of Primatene® Mist, an over-the-counter epinephrine inhaler that has been unavailable since January as part of a phase out of products containing ozone-depleting chlorofluorocarbons. The draft bills will be formally introduced this week.